Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit;Solunumsal yoǧun bakim ünitesinde çoklu antibiyotik dirençli Acinetobacter baumannii enfeksiyonu

Mikrobiyoloji Bulteni

Volumn 43, Issue 4, 2009, Pages 575-585

  Bacakoǧlu, Feza ^a   Korkmaz, Pervin Ekren ^a   Taşbakan, Mehmet Sezai ^a   Başarik, Burcu ^a   Pullukçu, Hüsnü ^a   Aydemir, Şöhret ^a   Gürgün, Alev ^a   Başoǧlu, Özen Kaçmaz ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acinetobacter baumannii; Intensive care unit; Multidrug resistant; Nosocomial infections; Pneumonia

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL PNEUMONIA; COMORBIDITY; CROSS INFECTION; DRUG EFFECT; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TURKEY (REPUBLIC); VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTEREMIA; COMORBIDITY; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROGNOSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 73249149557     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9.
2. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-20.
3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
4. French GL, Philips I. Antimicrobial resistance in hospital flora and nosocomial infections, pp: 980-99. In: Mayhall CG (ed), Hospital Epidemiology and Infection Control. 1996. Williams & Wilkins, Baltimore.
5. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance program, 1997-1999. Clin Infect Dis 2001; 32: S146-S55.
6. Rahal JJ, Urban C. Acinetobacter. Semin Respir Crit Care Med 2000;21:341-8.
7. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multi-drug resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32: S104-S13.
8. Bouvet PJM, Grimont PAD. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov,. Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter Iwoffii. Int J Syst Bacteriol 1986;36:228-40.
9. Rello J. Acinetobacter pneumonia infections in the ICU. Chest 2005;115:1226-9.
10. Gaynes R, Edwards JR, and the National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-54.
11. Allen DM, Hartman BJ. Acinetobacter species, pp: 2009-13. In: Mandell GL, Douglas RG, Bennett JE (eds), Principles and Practices of Infectious Diseases. 1995, Churchill Livingstone, New York.
12. th Information Supplement, Document M100-A15, 2005. CLSI, Wayne, Pa.
13. Akkurt L, Güdül Havuz S, Uyar Y, Karadaǧ A, Esen Ş, Günaydin M. 1999-2000 yillarinda yoǧun bakim ünitesinden izole edilen bakterilerde antibiyotik direnci. ANKEM 2002;16:14-7.
14. Aygün G, Dikmen Y, Mete B ve ark. Yoǧun bakim ünitesinde hastane enfeksiyonu etkeni olarak belirlenen Acinetobacter baumannii kökenlerinin antibiyotik duyarliliǧi. ANKEM 2002;16:85-8.
15. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-65.
16. Buisson Y, Tran Van Nhieu G, Ginot L, et al. Nosocomial outbreaks due to amikacin-resistant tobramycinsensitive Acinetobacter species: correlation with amikacin usage. J Hosp infect 1990;15:83-93.
17. Joly-Guillou ML, Decre D, Bergogne-Berezin E. Infections nosocomials a Acinetobacter. surveillance epidemiologique hospitaliere. Bull Epidemiol Hebd 1992;vl:211-2.
18. Struelens MJ, Carlier E, Maes N, Serruys E, Quint WG, Van Belkum A. Nosocomial colonisation and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J Hosp Infect 1993;25:15-32.
19. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93.
20. Rola N, Lawrence H, Goldstein S, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82.
21. Mulin B, Talon D, Viel JF, et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumanii. Eur J Clin Microbiol Infect Dis 1995;14:569-76.
22. Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J. Risk factors for infection by Acinetobacter baumanii in intubated patients with nosocomial pneumonia. Chest 1997;112:1050-4.
23. Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 1995;16:92-7.
24. Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. J Parenter Enteral Nutr 2002;26:174-81.
25. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine 1995;74:340-9.
26. Cisneros JM, Reyes MJ, Paction J, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical and prognostic features. Clin Infect Dis 1996;22:1026-32.
27. Beck-Sague CM, Jarvis WR, Brook JH, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 1990;132:723-33.
28. Tilley PAG, Roberts FJ. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis 1994;18:896-900.
29. Craven PE. Epidemiology of ventilator associated pneumonia. Chest 2000;117:186-7.
30. Turner PJ, Creenhalgh JM; MYSTIC Study Group (Europe) : the activity of meropenem and comparators against Acinetobactepr strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 2003;9:563-7.